文献速递血栓与止血

英国外部质量评估计划对VITT与HIT的抗PF4检测分析

Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021.
PubMed 文献 · J Thromb Haemost · 2021-07-05

该研究通过英国国家外部质量评估计划,向85家进行HIT检测的中心分发VITT患者、经典HIT患者混合及非VITT/非HIT的液体和冻干样本。结果显示部分抗PF4 ELISA法能检出VITT抗体,而Acustar HIT、Werfen LIA和Stago STIC法未能检出,提示临床和实验室团队需认识某些抗PF4检测方法在辅助诊断VITT综合征时的局限性。

要点

  • 部分抗PF4 ELISA法可检出VITT抗体,但Acustar HIT、Werfen LIA和Stago STIC法未能检出。
  • 液体和冻干样本在抗PF4抗体ELISA检测中具有互换性。
  • 临床和实验室团队应了解某些抗PF4检测方法在VITT诊断中的局限性。

核心结论

  • 临床和实验室团队需了解某些抗PF4检测方法在辅助诊断VITT综合征时的局限性。

研究设计与样本

  • 英国国家外部质量控制评估计划向85家进行HIT检测的中心分发VITT患者、经典HIT患者混合及非VITT/非HIT的液体和冻干样本,各中心采用本地验证的HIT检测方法。

主要发现

  • 液体和冻干样本在抗PF4抗体ELISA检测中具有互换性。
  • Aeskulisa、Stago、Hyphen和LIFECODES抗PF4 ELISA法成功检出VITT抗体。
  • Acustar HIT、Werfen LIA和Stago STIC法未能检出VITT抗体。

临床怎么用

  • 临床和实验室团队应了解某些抗PF4检测方法在辅助诊断VITT综合征时的局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccine-induced immune thrombocytopenia and thrombosis (VITT) following the administration of the AstraZeneca (AZ) ChAdOx1 nCOV-19 vaccine has recently been reported. The associated clinical and laboratory features have included thrombosis at unusual sites, thrombocytopenia, and raised D-dimers with positivity for IgG anti-platelet factor 4 (PF4) antibodies. OBJECTIVES: A UK National External Quality Control Assessment Scheme external quality control exercise was carried out by distributing liquid and lyophilized samples from a subject with VITT, a pool of samples from subjects with classical heparin-induced thrombocytopenia (HIT), and a non-VITT/non-HIT case to 85 centers performing HIT testing. METHODS: Participating centers employed their locally validated testing methods for HIT assays. RESULTS: The lyophilized and liquid samples were found to be commutable for the ELISA assays used in the detection of anti-PF4 antibodies. The Aeskulisa, Stago, Hyphen, and LIFECODES anti-PF4 ELISA assays successfully detected the VITT antibody, whereas the Acustar HIT, Werfen LIA, and the Stago STIC assays did not. CONCLUSION: It is important that clinical and laboratory teams are aware of the limitations of some anti-PF4 assays when using them to aid diagnosis of VITT syndrome.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Reilly-Stitt C, Kitchen S, Jennings I, et al. Anti-PF4 testing for vaccine-induced immune thrombocytopenia and thrombosis and heparin induced thrombocytopenia: Results from a UK National External Quality Assessment Scheme exercise April 2021. J Thromb Haemost. 2021. PMID: 34227230. doi:10.1111/jth.15423

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。